Response to sunitinib in combination with proton beam radiation in a patient with chondrosarcoma: a case report
نویسندگان
چکیده
INTRODUCTION Chondrosarcoma is well-known to be primarily resistant to conventional radiation and chemotherapy. CASE PRESENTATION We present the case of a 32-year-old Caucasian man with clear cell chondrosarcoma who presented with symptomatic recurrence in his pelvis and metastases to his skull and lungs. Our patient underwent systemic therapy with sunitinib and then consolidation with proton beam radiation to his symptomatic site. He achieved complete symptomatic relief with a significantly improved performance status and had an almost complete and durable metabolic response on fluorine-18-fluorodeoxyglucose positron emission tomography. CONCLUSIONS Our findings have important clinical implications and suggest novel clinical trials for this difficult to treat disease.
منابع مشابه
Chondrosarcoma of cranial vault: case report and review of literature
Chondrosarcoma is a rare malignant cartilage forming tumour usually arising from long bones and rarely seen in cranium. In cranium it is seen to commonly arises from skull base with skull vault being a highly unusual site. We report a case of a 30-year female presenting with complaints of headache for 6 months found to have a large chondrosarcoma in right fronto-parietal region which is an extr...
متن کاملInvestigation of tumor motion influence on applied dose distribution in conventional proton therapy vs. IMPT a 4D Monte Carlo simulation study
Background: in radiation treatment of moving targets located in thorax region of patient body, the delivered dose does not match with the planned treatment, resulting in some over and under dosage in the tumor volume, as a function of motion magnitude and frequency. Several efforts have been done to investigate the target motion effects on dose distribution in the target and surrounding normal ...
متن کاملSinonasal Teratocarcinosarcoma Report of a case
Sinonasal teratocarcinosarcoma (SNTCS) is a rare tumor characterized by mixture architecture of epithelial and mesenchymal components. SNTCS is a highly malignant tumor displaying progressive and aggressive growth with poor prognosis. Only about 40% of all patients survive after five years. It seems the combination of surgery and radiotherapy currently is the most effective treatment. In this r...
متن کاملPituitary Chondrosarcoma presenting as a sellar and suprasellar mass with parasellar extension: An Unusual presentation
Chondrosarcoma is a mesenchymal tumor composed of tumor cells producing cartilage. It is more common in older age and often affects the axial skeleton. We report a rare case of chondrosarcoma mimicking a sellar and suprasellar mass with parasellar extension. A 40 yr woman presented with decreasing visual acuity and headache. Magnetic resonance (MR) image revealed a cystic sellar and suprasellar...
متن کاملSunitinib Induced Immune Thrombocytopenia
Sunitinib is an oral tyrosine kinase inhibitor which prevents tumor growth and metastatic progression. It was approved for treatment of advanced renal cell cancer, gastrointestinal stromal tumor and advanced pancreatic neuroendocrine tumors. It has several adverse reactions on multi organ systems including hematologic system. Although the neutropenia and thrombocytopenia commonly happens as Gra...
متن کامل